About CapsoVision
CapsoVision is a company based in Saratoga (United States) founded in 2006. CapsoVision has raised $117.53 million across 14 funding rounds. CapsoVision offers products and services including CapsoCam Plus. CapsoVision operates in a competitive market with competitors including Mauna Kea Tech, EchoSens, Smart Medical Systems, Invendo Medical and GI View, among others.
- Headquarter Saratoga, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Capsovision, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$117.53 M (USD)
in 14 rounds
-
Latest Funding Round
$980 K (USD), Series E
Jun 17, 2020
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CapsoVision
CapsoVision is a publicly listed company on the NASDAQ with ticker symbol CV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of CapsoVision
CapsoVision offers a comprehensive portfolio of products and services, including CapsoCam Plus.
Provides 360-degree panoramic imaging for small bowel abnormality detection in patients.
People of CapsoVision
Unlock access to complete
Funding Insights of CapsoVision
CapsoVision has successfully raised a total of $117.53M across 14 strategic funding rounds. The most recent funding activity was a Series E round of $980 thousand completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series E — $980,000
-
First Round
First Round
(01 Oct 2006)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Series E - CapsoVision | Valuation |
investors |
|
| Nov, 2019 | Amount | Series E - CapsoVision | Valuation |
investors |
|
| Aug, 2018 | Amount | Series D - CapsoVision | Valuation |
investors |
|
Investments & Acquisitions by CapsoVision
Financial Statements - CapsoVision
Capsovision Comparisons
Competitors of CapsoVision
CapsoVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mauna Kea Tech, EchoSens, Smart Medical Systems, Invendo Medical and GI View, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Endomicroscopy devices are developed for gastrointestinal and respiratory endoscopy.
|
|
| domain | founded_year | HQ Location |
Non-invasive diagnostics for liver disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Endoscopes and devices for GI diagnosis and treatment are produced.
|
|
| domain | founded_year | HQ Location |
Sterile single-use robotics-based endoscopes are developed for gastroenterology.
|
|
| domain | founded_year | HQ Location |
Devices for GI disorder diagnosis and treatment are developed.
|
Frequently Asked Questions about CapsoVision
CapsoVision was founded in 2006.
CapsoVision is headquartered in Saratoga, United States. It is registered at Saratoga, California, United States.
CapsoVision is a funded company, having raised a total of $117.53M across 14 funding rounds to date. The company's 1st funding round was a Series D of $6.06M, raised on Oct 01, 2006.
CapsoVision is a digital imaging devices company for medical applications. Its initial product offering includes the CapsoCam SV1, a GI capsule endoscopy system for the diagnosis of small bowel diseases including bleeding, cancer, celiac and Crohns disease. According to the company, it provides 360 degree imaging of the intestinal wall. The capsule records and self-stores the data.
CapsoVision's top competitors include EchoSens, Mauna Kea Tech and Invendo Medical.
CapsoVision offers CapsoCam Plus.
Yes, CapsoVision is publicly traded on NASDAQ under the ticker symbol CV.
The ticker symbol of CapsoVision is CV on NASDAQ.